The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
20101174: Lindsay Goldberg III L.P.; Philip J. Edmundson
20101186: Noble Group Limited; Sempra Energy
20101184: Noble Group Limited; The Royal Bank of Scotland Group plc
20101177: Churchill Downs Incorporated; SWG Holdings, LLC
20101171: GDF SUEZ S.A.; International Power plc
DCM Services LLC
In the Matter of The Coca-Cola Company; Analysis of Agreement Containing Consent Order to Aid Public Comment
FTC Comment Before the Federal Energy Regulatory Commission Concerning Demand Response Compensation in Organized Wholesale Energy Markets (Docket No. RM10-17-000)
Novartis AG, In the Matter of (Alcon, Inc)
To settle FTC charges that its proposed acquisition of Alcon, Inc., would be anticompetitive, Novartis AG agreed to sell an injectable eye care drug used in cataract surgery. Novartis and Alcon are the only two U.S. providers of the class of drugs known as injectable miotics, and the FTC alleges that the acquisition would have created a monopoly in injectable miotics. The settlement requires Novartis to sell its drug Miochol-E to Bausch & Lomb, Inc.